Immune Pharmaceuticals Inc – Files Chapter 11 as Key Creditor Threatens to Sell Collateral at Virgin Islands Auction

February 17, 2019 – Immune Pharmaceuticals Inc (“Immune” or the “Company”) filed for Chapter 11 protection with the U.S. Bankruptcy Court in the District of New Jersey, case number 19-13273. The Company, a biopharmaceutical company developing therapeutic agents for the treatment of immunologic and inflammatory diseases, is represented by Morris S. Bauer of Norris McLaughlin…